Jiajie Ji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jiajie Ji has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Kuanyu Li
Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, China
2 shared publications - Shuangying Hao
Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, China
2 shared publications - Tong Qiao
Department of Vascular Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
2 shared publications - Hongting Zhao
Jiangsu Provincial Traditional Chinese Medicine Obstetrics and Gynecology Reproductive Clinical Medical Innovation Center, Nanjing, China
1 shared publication - Huihui Li
Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, China
1 shared publication - Jing Wu
Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, China
1 shared publication
Latest Publications
- Open Access
Mitochondrion-Targeted Peptide SS-31 Inhibited Oxidized Low-Density Lipoproteins-Induced Foam Cell Formation through both ROS Scavenging and Inhibition of Cholesterol Influx in RAW264.7 Cells
Foam cell formation as a result of imbalance of modified cholesterol influx and efflux by macrophages is a key to the occurrence and development of atherosclerosis. Oxidative stress is thought to be involved in the pathogenesis of atherosclerosis. SS-31 is a member of the Szeto-Schiller (SS) peptides shown to specifically target the inner mitochondrial membrane to scavenge reactive oxygen species. In this study, we investigated whether SS-31 may provide protective effect on macrophage from foam cell formation in RAW264.7 cells. The results showed that SS-31 inhibited oxidized low-density lipoproteins (ox-LDL)-induced foam cell formation and cholesterol accumulation, demonstrated by intracellular oil red O staining and measurement of cholesterol content. The mechanism was revealed that SS-31 did not only significantly attenuated ox-LDL-induced generation of reactive oxygen species (ROS) and increased the activities of superoxide dismutases, but also dose-dependently inhibited the expression of CD36 and LOX-1, two scavenger receptors of ox-LDL, while the expression of ATP-binding cassette A1 and G1, playing a pivotal role in cholesterol efflux, was not affected. As a result, SS-31 decreased pro-inflammatory cytokines such as interleukin 6 and tumor necrosis factor alpha, suggesting the prevention of inflammatory responses. In conclusion, our results demonstrate that SS-31 provides a beneficial effect on macrophages from foam cell formation, likely, through both ROS scavenging and inhibition of cholesterol influx. Therefore, SS-31 may potentially be of therapeutic relevance in prevention of human atherogenesis.
Open AccessMitochondrion-Targeted Peptide SS-31 Inhibited Oxidized Low-Density Lipoproteins-Induced Foam Cell Formation through both ROS Scavenging and Inhibition of Cholesterol Influx in RAW264.7 Cells
Foam cell formation as a result of imbalance of modified cholesterol influx and efflux by macrophages is a key to the occurrence and development of atherosclerosis. Oxidative stress is thought to be involved in the pathogenesis of atherosclerosis. SS-31 is a member of the Szeto-Schiller (SS) peptides shown to specifically target the inner mitochondrial membrane to scavenge reactive oxygen species. In this study, we investigated whether SS-31 may provide protective effect on macrophage from foam cell formation in RAW264.7 cells. The results showed that SS-31 inhibited oxidized low-density lipoproteins (ox-LDL)-induced foam cell formation and cholesterol accumulation, demonstrated by intracellular oil red O staining and measurement of cholesterol content. The mechanism was revealed that SS-31 did not only significantly attenuated ox-LDL-induced generation of reactive oxygen species (ROS) and increased the activities of superoxide dismutases, but also dose-dependently inhibited the expression of CD36 and LOX-1, two scavenger receptors of ox-LDL, while the expression of ATP-binding cassette A1 and G1, playing a pivotal role in cholesterol efflux, was not affected. As a result, SS-31 decreased pro-inflammatory cytokines such as interleukin 6 and tumor necrosis factor alpha, suggesting the prevention of inflammatory responses. In conclusion, our results demonstrate that SS-31 provides a beneficial effect on macrophages from foam cell formation, likely, through both ROS scavenging and inhibition of cholesterol influx. Therefore, SS-31 may potentially be of therapeutic relevance in prevention of human atherogenesis.
- 1 September 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 464 (4) , 1134-1138
Low expression of ferroxidases is implicated in the iron retention in human atherosclerotic plaques
- 1 September 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 464 (4) , 1134-1138
Low expression of ferroxidases is implicated in the iron retention in human atherosclerotic plaques
- 25 August 2015
- Vol. 95 (32) , 2639-43
[Testing the influence of lipid laden and iron-overloading on ceruloplasmin expression in RAW 264.7 cells].
To investigate whether the treatment of oxidized low density lipoprotein (ox-LDL) could reduce ceruloplasmin (Cp) expression and then, influence iron efflux in macrophages. RAW264.7 cells were treated by lipopolysaccharides (LPS), ferric ammonium citrate (FAC), deferoxamine (DFO) and ox-LDL. Biochemical analysis and histological assays were performed to detect the iron-related protein including ferritin (Ft), transferrin receptor (TfR), ferroportin 1 (FPN1) and Cp. And the cholesterol enzyme was used to evaluate cells' cholesterol content. Western blot showed that protein level of FPN1, Ft increased and protein level of TfR decreased after the treatment of FAC. The mRNA level (t=-5.995, P=0.019) and the oxidative activity (t=-9.875, P=0.001) of Cp increased significantly after the treatment of LPS+FAC compared to control group. The treatment of ox-LDL could reduce protein level of Cp compared to LPS treated cells and no different protein levels of Ft and Ferroportin was found after the treatment of ox-LDL as shown by Western blot. The protein level, ferroxidase activities (t=6.663, P=0.003) and mRNA levels (t=8.948, P=0.001) of Cp in LPS+ox-LDL+FAC group were reduced than LPS+FAC group. The protein levels of Ft and FPN1 in LPS+ox-LDL+FAC group was significant higher than LPS+FAC group as shown by Western blot. The findings suggest that the expression of Cp is reduced in foam cells and leads to obstructed iron efflux in iron overloaded foam cells.
- 25 August 2015
- Vol. 95 (32) , 2639-43
[Testing the influence of lipid laden and iron-overloading on ceruloplasmin expression in RAW 264.7 cells].
To investigate whether the treatment of oxidized low density lipoprotein (ox-LDL) could reduce ceruloplasmin (Cp) expression and then, influence iron efflux in macrophages. RAW264.7 cells were treated by lipopolysaccharides (LPS), ferric ammonium citrate (FAC), deferoxamine (DFO) and ox-LDL. Biochemical analysis and histological assays were performed to detect the iron-related protein including ferritin (Ft), transferrin receptor (TfR), ferroportin 1 (FPN1) and Cp. And the cholesterol enzyme was used to evaluate cells' cholesterol content. Western blot showed that protein level of FPN1, Ft increased and protein level of TfR decreased after the treatment of FAC. The mRNA level (t=-5.995, P=0.019) and the oxidative activity (t=-9.875, P=0.001) of Cp increased significantly after the treatment of LPS+FAC compared to control group. The treatment of ox-LDL could reduce protein level of Cp compared to LPS treated cells and no different protein levels of Ft and Ferroportin was found after the treatment of ox-LDL as shown by Western blot. The protein level, ferroxidase activities (t=6.663, P=0.003) and mRNA levels (t=8.948, P=0.001) of Cp in LPS+ox-LDL+FAC group were reduced than LPS+FAC group. The protein levels of Ft and FPN1 in LPS+ox-LDL+FAC group was significant higher than LPS+FAC group as shown by Western blot. The findings suggest that the expression of Cp is reduced in foam cells and leads to obstructed iron efflux in iron overloaded foam cells.